发明申请
- 专利标题： USE OF ISATUXIMAB FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
-
申请号： US17112862申请日： 2020-12-04
-
公开(公告)号： US20210171653A1公开(公告)日： 2021-06-10
- 发明人: Marie-Laure RISSE , Gaelle ASSET
- 申请人： Sanofi-Aventis U.S. LLC , Sanofi
- 申请人地址： US NJ Bridgewater; FR Paris
- 专利权人： Sanofi-Aventis U.S. LLC,Sanofi
- 当前专利权人： Sanofi-Aventis U.S. LLC,Sanofi
- 当前专利权人地址： US NJ Bridgewater; FR Paris
- 优先权： EP20315186.5 20200417
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61P35/00 ; A61K31/573 ; A61K31/5355
摘要：
The present disclosure provides methods for treating multiple myeloma (such as refractory multiple myeloma or relapsed and refractory multiple myeloma) in an individual who received one to three prior therapies (or prior lines of therapy) for multiple myeloma. The methods comprise administering to the individual an anti-CD38 antibody, carfilzomib, and dexamethasone.
公开/授权文献
- US3267011A Monoalkylhydrazine synthesis 公开/授权日：1966-08-16
信息查询
